PFIZER INC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$164.2M2026 Q3
Positions17
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.95.1%

PFIZER INC reported 17 positions worth $164.2M as of September 30, 2026 (13F filed November 12, 2026). Largest holding: ALLO (22.1%).

10 / 17 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 ALLOAllogene Therapeutics$36.4M22.13%22,032,040——-47.6%
▸ 2 ARVNArvinas$26.2M15.98%3,457,815——-11.9%
▸ 3 CELCCelcuity$23.5M14.31%295,652——-19.1%
▸ 4 AGMBAgomAb Therapeutics$22.6M13.77%2,151,213——-42.7%
▸ 5 PYXSPyxis Oncology$20.1M12.25%7,032,770——-32.2%
▸ 6 WVEWave Life Sciences$7.1M4.32%1,875,000——-15.4%
▸ 7 BHVNBiohaven$6.6M4.00%505,645———
▸ 8 CRBUCaribou Biosciences$5.8M3.54%4,690,431———
▸ 9 ORICOric Pharmaceuticals$4.9M2.99%372,904——-41.6%
▸ 10 CRDFCardiff Oncology$3.0M1.82%2,411,575——-19.8%

Pro Feature

The remaining 7 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does PFIZER INC hold as of Q3 2026?

PFIZER INC reported 17 positions worth $164.2M in its Q3 2026 13F filing. Largest positions: ALLO (22.1%), ARVN (16.0%), CELC (14.3%), AGMB (13.8%) and PYXS (12.2%).

What did PFIZER INC buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did PFIZER INC sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.